Comparative Safety and Efficacy Evaluation Between Dermacyd Silver and Glycerine Vegetal Soap Granado Traditional

NCT ID: NCT01126606

Last Updated: 2010-12-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

70 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-08-31

Study Completion Date

2010-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Primary Objective:

To evaluate the potential of hydratation and renewal of the mucosa, through corneometry measurement and individual questionnaire perception.

Secondary Objective:

To evaluate the safety in normal condition of use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hygiene

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1

Dermacyd Silver Frutal followed by Dermacyd Silver Frutal+PH\_DESYLSTY\_FR followed by wash out followed by Glycerine Vegetal Soap Granado Traditional

Group Type EXPERIMENTAL

Dermacid Silver (Lactic acid)

Intervention Type DRUG

Liquid soap, daily use

Glycerine Vegetal Soap Granado Traditional

Intervention Type DRUG

Vegetal soap, daily use

Group 2

Glycerine Vegetal Soap Granado Traditional followed by wash out followed by Dermacyd Silver Floral followed by Dermacyd Silver Floral + PH\_DESYLSTY\_FR

Group Type EXPERIMENTAL

Dermacid Silver (Lactic acid)

Intervention Type DRUG

Liquid soap, daily use

Glycerine Vegetal Soap Granado Traditional

Intervention Type DRUG

Vegetal soap, daily use

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dermacid Silver (Lactic acid)

Liquid soap, daily use

Intervention Type DRUG

Glycerine Vegetal Soap Granado Traditional

Vegetal soap, daily use

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Active sex life
* Menopause for at least 6 months
* Perfect mucosa in the evaluated area
* Use the same cosmetics category

Exclusion Criteria

* Use of antiinflammatory / immunosuppression / antihistaminic drugs
* Personal history of atopy to cosmetic products
* Cutaneous active disease (local and/or general) in the evaluated area
* Disease which can cause immunosuppression, such as diabetes, HIV
* Endocrine pathology such as thyroid disease, ovarian disorder or adrenal gland
* Intense solar exposure (to get a tan) during the 15 days before the evaluation
* Gynaecologic treatment until four weeks before the evaluation
* Whatever vaginal infection detected at time of inclusion
* Other conditions considered by the investigator as reasonable to exclude the patient from the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.
Minimum Eligible Age

45 Years

Maximum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanofi

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

sanofi-aventis

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clinical Sciences & Operations

Role: STUDY_DIRECTOR

Sanofi

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Sanofi-Aventis Administrative Office

São Paulo, , Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

LACAC_L_04937

Identifier Type: -

Identifier Source: org_study_id